{"id":45678,"date":"2022-06-30T12:01:37","date_gmt":"2022-06-30T10:01:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/"},"modified":"2022-06-30T12:01:37","modified_gmt":"2022-06-30T10:01:37","slug":"alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/","title":{"rendered":"Alto Pharmacy Appoints Alicia Boler Davis as CEO to Drive Next Phase of Growth"},"content":{"rendered":"
\n

\nAlicia Boler Davis brings more than 25 years of experience leading world-class technology operations<\/i>\n<\/p>\n

SAN FRANCISCO–(BUSINESS WIRE)–Alto Pharmacy today announced Alicia Boler Davis will become CEO on September 1, 2022. Alicia was recruited by co-founders and current co-CEOs Jamie Karraker and Matt Gamache-Asselin to scale the business that is transforming a $500 billion industry by reinventing what a pharmacy can do\u2014from hand-delivering medications for free to offering on-call help by text or chat.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nAlicia brings more than 25 years of technology and leadership experience from Amazon and General Motors to lead Alto as it scales and drives its next phase of growth. Jamie and Matt will continue to support Alto\u2019s mission full-time and will retain their seats on the Board. Both leaders will continue to be involved in the day-to-day business operations and will partner with Alicia to support her leadership and the transition.\n<\/p>\n

\n\u201cI have seen first-hand that lack of access to prescriptions and medical non-compliance can cause health to deteriorate, especially in elderly or immunocompromised people. Alto addresses this holistically and improves health outcomes for its customers through preventative care and easy access to quality treatments. Alto is in the business of improving health, not just fulfilling and delivering prescriptions. I am proud to join Matt and Jamie and lead Alto on its mission to improve the pharmacy experience for everyone,\u201d said Alicia Boler Davis.\n<\/p>\n

\nWith Alicia joining, Alto is taking another step forward in improving the broken pharmacy experience by unlocking potential at every step of the prescription process. She brings the experience and leadership to continue building Alto\u2019s team and culture of high-performance while putting people first, both customers and employees.\n<\/p>\n

\n\u201cWhat we\u2019ve tried to create at Alto is a company in healthcare that is both financially successful AND truly cares about the humans we serve and help every day. It takes a very unique combination of skills to do that, but Alicia has proven that\u2019s who she is,\u201d said Jamie Karraker co-founder and co-CEO, Alto Pharmacy.\n<\/p>\n

\nAlicia began her career at General Motors, where she spent nearly 25 years in manufacturing, product development, customer experience, and product quality. She most recently served as the Senior Vice President of Global Customer Fulfillment at Amazon. In this role, she led a number of teams, including Worldwide Fulfillment, which consists of hundreds of fulfillment centers around the world, Global Customer Service and Global Robotics. Alicia has a bachelor\u2019s degree in chemical engineering from Northwestern University, a Master\u2019s in Engineering Science from Rensselaer Polytechnic Institute, an MBA from Indiana University and an honorary doctorate of engineering from Rensselaer. Among other awards and accolades, in 2018 Alicia was named one of The Most Powerful Female Engineers by Business Insider, Black Engineer of the Year by Career Communications Group, and in 2020 and 2021 Alicia was named one of Fortune\u2019s Most Powerful Women.\n<\/p>\n

\nAlto Pharmacy was founded in 2015 on the belief that pharmacies should be focused on the patient experience. Today, Alto is an on-demand pharmacy that offers patients free same-day prescription delivery, cost transparency, and pharmacist access. Alto is helping people lead healthier lives through easy, fair access to medicine. For more information about Alto Pharmacy, visit www.alto.com<\/a>.\n<\/p>\n

\nAbout Alto<\/b>\n<\/p>\n

\nAlto is transforming a $500 billion industry by unlocking potential at every step of the prescription process. From the software in the doctor\u2019s office, through benefits and price investigation, to hand-delivery to people\u2019s homes and ongoing patient support, Alto\u2019s platform delivers a level of value and care far beyond people\u2019s expectations of traditional retail or digital pharmacies. When a pharmacy can turn the prescription process into healthcare progress, it ensures medicine can fulfill its true purpose. For more information, go to www.alto.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMichael Krueger
\n
press@alto.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Alicia Boler Davis brings more than 25 years of experience leading world-class technology operations SAN FRANCISCO–(BUSINESS WIRE)–Alto Pharmacy today announced Alicia Boler Davis will become CEO on September 1, 2022. Alicia was recruited by co-founders and current co-CEOs Jamie Karraker and Matt Gamache-Asselin to scale the business that is transforming a $500 billion industry by … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45678","6":"format-standard","7":"category-industry"},"yoast_head":"\nAlto Pharmacy Appoints Alicia Boler Davis as CEO to Drive Next Phase of Growth - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alto Pharmacy Appoints Alicia Boler Davis as CEO to Drive Next Phase of Growth - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Alicia Boler Davis brings more than 25 years of experience leading world-class technology operations SAN FRANCISCO–(BUSINESS WIRE)–Alto Pharmacy today announced Alicia Boler Davis will become CEO on September 1, 2022. Alicia was recruited by co-founders and current co-CEOs Jamie Karraker and Matt Gamache-Asselin to scale the business that is transforming a $500 billion industry by ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-30T10:01:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220630005304\/en\/1501832\/21\/ABD_Headshot.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Alto Pharmacy Appoints Alicia Boler Davis as CEO to Drive Next Phase of Growth\",\"datePublished\":\"2022-06-30T10:01:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\\\/\"},\"wordCount\":640,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220630005304\\\/en\\\/1501832\\\/21\\\/ABD_Headshot.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\\\/\",\"name\":\"Alto Pharmacy Appoints Alicia Boler Davis as CEO to Drive Next Phase of Growth - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220630005304\\\/en\\\/1501832\\\/21\\\/ABD_Headshot.jpg\",\"datePublished\":\"2022-06-30T10:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220630005304\\\/en\\\/1501832\\\/21\\\/ABD_Headshot.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220630005304\\\/en\\\/1501832\\\/21\\\/ABD_Headshot.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alto Pharmacy Appoints Alicia Boler Davis as CEO to Drive Next Phase of Growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alto Pharmacy Appoints Alicia Boler Davis as CEO to Drive Next Phase of Growth - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/","og_locale":"en_US","og_type":"article","og_title":"Alto Pharmacy Appoints Alicia Boler Davis as CEO to Drive Next Phase of Growth - Pharma Trend","og_description":"Alicia Boler Davis brings more than 25 years of experience leading world-class technology operations SAN FRANCISCO–(BUSINESS WIRE)–Alto Pharmacy today announced Alicia Boler Davis will become CEO on September 1, 2022. Alicia was recruited by co-founders and current co-CEOs Jamie Karraker and Matt Gamache-Asselin to scale the business that is transforming a $500 billion industry by ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-30T10:01:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220630005304\/en\/1501832\/21\/ABD_Headshot.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Alto Pharmacy Appoints Alicia Boler Davis as CEO to Drive Next Phase of Growth","datePublished":"2022-06-30T10:01:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/"},"wordCount":640,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220630005304\/en\/1501832\/21\/ABD_Headshot.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/","url":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/","name":"Alto Pharmacy Appoints Alicia Boler Davis as CEO to Drive Next Phase of Growth - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220630005304\/en\/1501832\/21\/ABD_Headshot.jpg","datePublished":"2022-06-30T10:01:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220630005304\/en\/1501832\/21\/ABD_Headshot.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220630005304\/en\/1501832\/21\/ABD_Headshot.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/alto-pharmacy-appoints-alicia-boler-davis-as-ceo-to-drive-next-phase-of-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Alto Pharmacy Appoints Alicia Boler Davis as CEO to Drive Next Phase of Growth"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45678"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45678\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}